Fig. 1 · Structure

Documents & Downloads

ICEC0942 HCl

Cat. No. A16903 CAS 1805789-54-1

CDK7 inhibitor

ICEC0942, also known as CT7001, is an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. It selectively inhibits CDK7, with an IC50 of 40nM; IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CDK7 IC50 41 nM
CDK2 IC50 578 nM
CDK1 IC50 1.8 μM
CDK4 IC50 49 μM
CDK5 IC50 9.4 μM
CDK6 IC50 34 μM
CDK9 IC50 1.2 μM

7 targets · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1805789-54-1
Applications CDK7 inhibitor
Formula C22H31ClN6O
Molecular Weight 430.98
Synonyms CT7001
SMILES
O[C@H]1CNCC[C@@H]1CNC2=NC3=C(C(C)C)C=NN3C(NCC4=CC=CC=C4)=C2.[H]Cl

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 76 mg/mL (176.34 mM)
Water 76 mg/mL (176.34 mM)
Ethanol 13 mg/mL (30.16 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...